(firstQuint)Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension.

 Renin-Angiotensin system blockade is a well established target for treatment of high blood pressure.

 Blocking the system at the initial step, however, is a rather new concept that could only be implemented very recently through the availability of novel, oral, renin inhibitors.

 This study investigates the safety and efficacy of a novel oral renin inhibitor, SPP635.

.

 Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension@highlight

This study is conducted to investigate the effect of the oral renin inhibitor SPP635 on blood pressure in patients with mild to moderate hypertension.

